Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases

Press/Media

Period20 Jan 2019

Media coverage

1

Media coverage